These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20209769)

  • 21. Rate of hypoglycaemia and insulin dosage in children during the initial therapy of type 1 diabetes mellitus.
    Herbst A; Roth CL; Dost AG; Fimmers R; Holl RW
    Eur J Pediatr; 2005 Oct; 164(10):633-8. PubMed ID: 16025296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
    Alotaibi A; Al Khalifah R; McAssey K
    Pediatr Diabetes; 2020 Nov; 21(7):1256-1267. PubMed ID: 32738022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe hypoglycaemia in children and adolescents during multiple-dose insulin therapy.
    Tupola S; Rajantie J; Mäenpää J
    Diabet Med; 1998 Aug; 15(8):695-9. PubMed ID: 9702475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe hypoglycemia in insulin-dependent diabetic children treated by multiple injection insulin regimen.
    Verrotti A; Chiarelli F; Blasetti A; Bruni E; Morgese G
    Acta Diabetol; 1996 Mar; 33(1):53-7. PubMed ID: 8777286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
    Nixon R; Pickup JC
    Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: prevalence and risk factors.
    Beregszàszi M; Tubiana-Rufi N; Benali K; Noël M; Bloch J; Czernichow P
    J Pediatr; 1997 Jul; 131(1 Pt 1):27-33. PubMed ID: 9255188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysglycemia among youth with type 1 diabetes and suboptimal glycemic control in the Flexible Lifestyle Empowering Change trial.
    Kahkoska AR; Crandell J; Driscoll KA; Kichler JC; Seid M; Mayer-Davis EJ; Maahs DM
    Pediatr Diabetes; 2019 Mar; 20(2):180-188. PubMed ID: 30536572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
    Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
    Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
    Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Education on Impaired Hypoglycemia Awareness and Glycemic Variability in Children and Adolescents with Type 1 Diabetes Mellitus.
    Demir G; Özen S; Çetin H; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):189-195. PubMed ID: 30701953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.
    Skogsberg L; Fors H; Hanas R; Chaplin JE; Lindman E; Skogsberg J
    Pediatr Diabetes; 2008 Oct; 9(5):472-9. PubMed ID: 18721168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes.
    Ziegler R; Heidtmann B; Hilgard D; Hofer S; Rosenbauer J; Holl R;
    Pediatr Diabetes; 2011 Feb; 12(1):11-7. PubMed ID: 20337978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Young children with type 1 diabetes can achieve glycemic targets without hypoglycemia: Results of a novel intensive diabetes management program.
    Phelan H; King B; Anderson D; Crock P; Lopez P; Smart C
    Pediatr Diabetes; 2018 Jun; 19(4):769-775. PubMed ID: 29504243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia.
    Morros-González E; Gómez AM; Henao Carrillo DC; Ursida V; Serrano S; Rondón Sepúlveda MA; Muñoz Velandia OM
    Diabetes Metab Syndr; 2021; 15(3):649-653. PubMed ID: 33813236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin pump treatment in children and adolescents with type 1 diabetes.
    Hofer S; Meraner D; Koehle J
    Minerva Pediatr; 2012 Aug; 64(4):433-8. PubMed ID: 22728614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
    Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
    Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Parton E; Totka J; Kirby M
    Acta Diabetol; 2003 Sep; 40(3):137-42. PubMed ID: 14605970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes.
    ; Tsalikian E; Tamborlane W; Xing D; Becker DM; Mauras N; Fiallo-Scharer R; Buckingham B; Weinzimer S; Steffes M; Singh R; Beck R; Ruedy K; Kollman C
    Diabetes Care; 2009 Nov; 32(11):1954-9. PubMed ID: 19675205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic control by insulin detemir in basal-bolus therapy: treat-to-target study in children and adolescents with type 1 diabetes.
    Nimri R; Lebenthal Y; Shalitin S; Benzaquen H; Demol S; Phillip M
    Pediatr Diabetes; 2013 May; 14(3):196-202. PubMed ID: 23289822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.